Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to reverse hyperglycemia and insulin dependency, by islet cell
transplantation, in patients with type 1 diabetes mellitus who have a stable kidney
allograft.
Phase:
Phase 2
Details
Lead Sponsor:
Rodolfo Alejandro
Collaborators:
Diabetes Research Institute Foundation Health Resources and Services Administration (HRSA) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institutes of Health (NIH)